Undefeated Tribe dba Crunch Fitness Franchise Names Jessica Johnson Chief Growth Officer

[ad_1]

The Undefeated Tribe dba Crunch Fitness made a significant investment in their executive leadership team and appointed Jessica Johnson as their new Chief Growth Officer. In this position, Johnson will be tasked with accelerating new club opening success and talent development. Johnson will join the team on November 1, and will be responsible for overseeing all new store opening projects, including $25 million dollars of projects already in the pipeline.

Jessica was previously the COO at YouFit Gyms and is a seasoned professional with over 21 years of fitness experience. She started her career as a Front Desk Team Member and in a short period of time, she began an extremely successful career which eventually led her to the Chief Operating Officer position with over 115 locations nationwide. Jess’ business intelligence, professionalism, and drive for excellence have been the foundation of her success and the respect she has earned from many team members over the years. She is passionate about developing and promoting people to levels they didn’t even know possible. She is happily married and enjoys spending time with her 3 children.

“Jessica is an experienced executive and transformative leader. She is an expert in leading end-to-end operational strategies and is a champion of people development. Jessica has the experience and expertise in leadership, management, and overall capability to accelerate the Crunch Fitness brand throughout Texas, Oklahoma, New Mexico, Colorado and Cincinnati,” said Tony Hartl, CEO and Founder of Crunch Fitness Austin.

With each new opening, The Undefeated Tribe brings new jobs to the markets they operate in, and with 15 more in development over the next 18 months, they are adding another 1,100 jobs. “The Undefeated Tribe management team has demonstrated the ability to maintain growth, all while executing on a strategy that continues to deliver industry leading results. Having Jessica on board, overseeing the new store opening projects will allow us to take hold of these opportunities at a faster pace, accelerating our overall growth rate and pushing to our ultimate goal of owning and operating 50 Crunch Fitness locations by 2025,” said Tony Hartl.

About Crunch Fitness

Crunch is a gym that believes in making serious exercise fun by fusing fitness and entertainment and pioneering a philosophy of ‘No Judgments.’ Crunch serves a fitness community for all types of people, with all types of goals, exercising all different ways; working it out at the same place together. Today, we are renowned for creating one-of-a-kind group fitness classes and unique programming for our wildly diverse members. Headquartered in New York City, Crunch serves over 1,500,000 members with over 350 gyms worldwide in 30 states, Puerto Rico, Canada, Spain and Australia, and Costa Rica. Crunch is rapidly expanding across the U.S. and around the globe.

Share article on social media or email:

[ad_2]

Spending on Wellness Is Strongly Associated with Greater Longevity & Happiness, Bolstering the Case for Wellness Policy, According to Global Wellness Institute Research

[ad_1]

News Image

We hope that this study and GWI’s upcoming wellness policy toolkits will kickstart a global conversation and more research in this area

As consumer spending on wellness has exploded into a multi-trillion market, it raises key questions: Is all this spending even improving people’s wellbeing and physical and mental health? Skeptics would guess no, but new research released today by the Global Wellness Institute (GWI) says, quite definitively, yes.

These findings are part of GWI’s historic new report, “Defining Wellness Policy,” the first research to define wellness policy and make a compelling, evidence-backed argument as to why it’s so direly needed. It explains how wellness policy can complement–but also fill the glaring gaps left by–both current public health policy and new happiness and wellbeing policy efforts. It also addresses the serious gaps in the sick-care-focused medical system and in the private sector wellness industry, that clearly cannot bring wellness to all. The report includes the first-ever quantitative analysis that determines the relationship between wellness spending, health outcomes, and happiness across countries. It demonstrated that spending on wellness is strongly and positively correlated with increased longevity and happiness, not only for the “wealthy well” but across the board.

“As we dived into this research, it quickly became obvious that health and wellness should be embedded in the priorities for all policymaking,” said Katherine Johnston, GWI senior research fellow. “As compared to sustainability – which has been in policy conversations for so long – it is astonishing that no one has talked about wellness as a comprehensive, cross-cutting policy category in government circles. The health of people should be paramount, just like the health of the planet, and really, the two go hand-in-hand. We hope that this study and GWI’s upcoming wellness policy toolkits will kickstart a global conversation and more research in this area.”

Download the free report here.

The research, unveiled at the Global Wellness Summit now being held in Tel Aviv, sets the stage for a series of Wellness Policy Toolkits to be released in 2023, which will provide governments, non-profits, communities and businesses a roadmap on how to take action in seven domains of wellness policy: physical activity, healthy eating, mental wellness, traditional/complementary medicine, wellness in the built environment, wellness at work, and wellness in tourism.

Wellness Spending = Increased Happiness and Longevity

To identify the relationship between wellness spending, happiness levels, and health outcomes, GWI researchers partnered with Dr. Shun Wang, a key author, and statistician of the World Happiness Report. Utilizing data from GWI’s wellness economy reports (measuring wellness spending in more than 200 markets), Gallup’s World Poll (for global happiness measurements), and the World Bank (for national life expectancy and income levels)–and then carefully adjusting for wealth levels and population size–a regression analysis revealed striking findings. Across countries, for every $844 increase in wellness spending per person, the average happiness level increases by nearly 7%. An increase of $769 in wellness spending per capita is associated with 1.26 years of extra life. While correlation does not necessarily mean causation, these important results clearly signal that there are health and wellbeing benefits from wellness spending. A forthcoming GWI white paper will expand on these results, analyzing the relationships between spending in each wellness sector–whether physical activity, healthy food, traditional medicine, or mental wellness–and how it’s associated with outcome measures for health and happiness.

“This is the first time that anyone has analyzed wellness economy spending alongside data on happiness and life expectancy, and we found that investment in wellness is definitely linked to positive outcomes in these metrics,” said Ophelia Yeung, GWI senior research fellow. “We believe that wellness policy is crucial for bringing the benefits of wellness to everyone, especially to those who cannot pay for it or who face barriers to living a healthy lifestyle.”

More on “Defining Wellness Policy”

GWI’s Wellness Policy series aims to build common language, frameworks, and strategies for governments, industry, and communities to work toward the goal of wellness for all. The report released today establishes why wellness is the missing link in policy, and how wellness policy can uniquely address the gaps in the current movements attempting to tackle our cascading health crises.

Wellness Policy – A Definition: GWI defines wellness policy as “a set of cross-cutting actions that encourage healthy lifestyles and create supportive environments for human health and wellbeing.” Wellness policy is specifically focused on prevention, lifestyle changes, and the many environmental factors that affect our wellbeing.

A Desperate Need for New Solutions: If health and wellbeing metrics were precarious before the pandemic, they’re now deteriorating further. We face escalating macro crises: worsening chronic disease, mental unwellness, sedentary lives, environmental destruction, an aging population, and the pressures of technology, all of which impose staggering economic costs. Global health expenditures more than doubled in the last decade, reaching $8.5 trillion annually and it is projected that chronic diseases and mental conditions will cost $47 trillion between 2011 and 2030; physical inactivity is a $67.5 billion annual burden and employee disengagement at work costs an estimated $7.8 trillion a year.

Wellness Policy Tackles:

Gaps in Healthcare & Public Health Policy: While research shows that 80-90% of our health outcomes are determined by environmental, socioeconomic, and lifestyle factors, healthcare remains primarily a “sick-care” model, while public health systems lack a mandate to address lifestyle and environmental factors. GWI estimates that only about 4% of annual global health expenditures are for prevention, risk reduction, and public health. Wellness policy refocuses public health policy on the lifestyle factors and environmental determinants of health that have the biggest impact on our wellbeing and longevity.

Gaps in the Consumer Wellness Market: The modern consumer wellness movement has accomplished much, including mainstreaming a concept of health that is holistic, destigmatizing mental health, and vastly increasing consumer choice. But it has left glaring gaps in accessibility and affordability, and cannot bring wellness to all. Among the $4.4 trillion of wellness economy spending in 2020, only 6% was in “lower-middle” and “low-income” countries. Wellness is a powerful concept for policy action because it taps into the language and aspirational desires of consumers, but can ensure that access to wellness is far more equitable and inclusive.

Gaps in Happiness & Wellbeing Policy: Happiness and wellbeing have entered the mainstream lexicon, but their impact on policy remains limited. The conversation is still mostly theoretical and only a few (mostly small and wealthy countries, such as New Zealand, Wales, and Scotland) have embedded happiness and wellbeing into their national budgeting priorities. The problem is that happiness and wellbeing policy takes a top-down approach that requires long-term, monumental change in how governments set priorities and allocate resources. In contrast, a wellness policy approach focuses on making incremental, immediate, bottom-up changes within existing policy structures, and changes that have a deeper impact on human health than merely improving subjective wellbeing.

This research was generously sponsored by these companies: Art of Cryo, Biologique Recherche, Blue Zones Center, Canyon Ranch, Carillon Miami Wellness Resort, Fountain Life, HB Reavis, The John W. Brick Foundation, Magleby Development, MindBody, Natura Bissé, Rancho La Puerta, Rancho Mission Viejo, Six Senses, Technogym and Universal Companies.

Graphs from the research are here.

About the Global Wellness Institute: The Global Wellness Institute (GWI), a nonprofit 501(c)(3), is considered the leading global research and educational resource for the global wellness industry and is known for introducing major industry initiatives and regional events that bring together leaders to chart the future. GWI positively impacts global health and wellness by educating public institutions, businesses and individuals on how they can work to prevent disease, reduce stress and enhance the overall quality of life. Its mission is to empower wellness worldwide.

[ad_2]

Kyowa Hakko USA Highlights Branded Ingredients and New Innovations at SupplySide West 2022

[ad_1]

Kyowa Hakko USA, leading international health ingredient manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products, announces featured events for IMMUSE™ a postbiotic that delivers a new, breakthrough approach to more comprehensive immune support* and Cognizin® Citicoline, a clinically studied and branded form of Citicoline.

IMMUSE™:

Wednesday, November 2, 2022 – 11:30 am – 12:20 pm, at Supplier Theater #3677

Heather Moday, MD, author of “The Immunotype Breakthrough,” will be speaking about “Building Immune Resilience Using Our Personal Immunotype,” and she will also discuss the novel postbiotic IMMUSE™ and its mode of action in providing more comprehensive immune support. The audience will be able to determine their own personal immunotype as Dr. Moday leads the discussion on how to balance the immune system.

Following the presentation, Dr. Moday will be at the Kyowa Hakko Booth # 3065 starting at 1:00 pm to sign her recent book, The Immunotype Breakthrough. Press is invited to stop by.

As a clinically researched immune activator* supported by 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.

Cognizin® Citicoline “Tap Challenge”:

The “Tap Challenge” app tests how quickly an individual can tap a button in 20 seconds. Great for training reflexes for more complex fighter games and games that need quick combinations, Tap Challenge truly gets your fingers moving. It looks simple but tapping with one finger, even for 20 seconds, is not that easy. Players can download the app from a QR code at the Kyowa Hakko booth and practice their tapping skills before facing off against the highest scorers at the show.

Qualifying rounds are on:

Wednesday Nov 2: 2:00pm – 4:00 pm

Thursday Nov 3: 10:00am – 11:30 am

At noon on Thursday, the players with the top 5 scores will tap off against each other to win Amazon Gift Cards!

1st Place: $250 Amazon Gift Card

2nd Place: $100 Amazon Gift Card

3rd Place: $50 Amazon Gift Card

“When we first debuted the test version at SxSW Gaming Expo in 2019, the response was overwhelming. So, we decided to make it available to everyone interested in powering their game,” commented Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc.

This all began following the results of a study that Kyowa Hakko initiated in 2015. Using a Finger Tap Test, the results supported improved attentional abilities, psychomotor speed and inhibition in healthy adolescent males when supplementing with Cognizin® Citicoline over a 30-day period (McGlade, et al., 2015). The double-blinded study was conducted by neuropsychologists using a variety of tests that simulated cognitive functions and keyboard actions like those exercised in PC video games.

An innovative form of citicoline, a potent brain-health nutrient and nootropic, Cognizin® has been extensively clinically studied to support mental energy, focus, memory, and attention*. Many other cognitive health ingredients only enhance brain performance. Cognizin® provides more comprehensive brain health support over time for gamers and anyone interested in supporting their overall cognitive health*.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About IMMUSE™:

IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by over 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells) *. The pDC, a rare type of immune cell, functions as the key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.

About Cognizin® Citicoline

Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health.* Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and memory. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, pure and allergen-free. Cognizin® is available in over 200 products. For more information on Cognizin®, visit Cognizin.com.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development,

manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food products. For more information, visit Kyowa-USA.com.

Media interested in setting up an interview with Heather Moday MD, or Karen Todd, please drop by the Kyowa Hakko booth # 3065 or call Sue Taggart at 917.833.8101.

[ad_2]

UnitedRx Combats Drug Diversion in Healthcare with New Solution, Cubex®

[ad_1]

UnitedRx Long Term Care Pharmacy

“Our objective with this technology is to develop a culture in which employees recognize the risks and take personal responsibility for reporting drug diversion in facilities and for the patients to whom we have an ethical and moral obligation,” said Chuck Benain, CEO of UnitedRx.

UnitedRx, the Midwest’s largest full-service, independent long-term care pharmacy, is combating drug diversion in skilled nursing facilities with cutting-edge technology such as Cubex®. To ensure that controlled substances are secure, accounted for, and always administered at the correct dosage, the medicine cabinet features extra security and automated logging.

“Our objective with this technology is to develop a culture in which employees recognize the risks and take personal responsibility for reporting drug diversion in facilities and for the patients to whom we have an ethical and moral obligation,” said Chuck Benain, CEO of UnitedRx.

The American Nurses Association reports that 10% of nurses are drug dependent. To illustrate, one in every ten nurses whom a patient comes in contact with is most likely struggling with addiction. With over 3 million nurses employed in the healthcare industry, this translates to an estimated 300,000 substance abusers.

Nurses who abuse drugs are more likely to be addicted to prescription medicines such as amphetamines, opiates, sedatives, tranquilizers, and inhalants, all of which are readily available in their workplaces. Drugs that may go unnoticed for a long time are also frequently accessible to healthcare practitioners, further adding to the problem of drug diversion among nurses and CNAs.

With UnitedRx’s Cubex Biometric security, nurses must use their fingerprints to access the cabinet containing over 400 drugs, allowing for the tracking of suspicious activities. The device, which is used as part of a complete diversion prevention and detection program, prohibits multiple access to drugs. Similarly, in order to monitor waste or returns, the system requires access from two users.

“By employing this technology within our organization and making it accessible as a methodology for other facilities to employ, we anticipate being able to considerably lessen the drug diversion crisis in the healthcare sector and incentivize people impacted to seek treatment,” said UnitedRx National Director of Sales and Marketing Melanie Williams

Based in Illinois, UnitedRx currently provides services to over 350 facilities across 20 states, totaling more than 36,000 beds at skilled nursing facilities, assisted living communities, group homes, intermediate care facilities (ICF-DD), and hospice. The organization prides itself on providing a friendly neighborhood pharmacy experience, pledging to exceed all expectations with state-of-the-art communication and packaging technologies, as well as custom and flexible solutions to address specific customer needs and centralized billing.

About UnitedRx

UnitedRx is one of the largest, full-service, independent long-term care pharmacies headquartered in Illinois. Developed in 2008, UnitedRx has grown to over 350 facilities consisting of skilled nursing facilities, assisted living communities, youth homes, intermediate care facilities (ICF-DD), and hospice care. UnitedRx serves over 36,000 beds across 20 states with pharmacy locations in Illinois, Pennsylvania, Kansas, Nevada, and Tennessee, while employing over 350 people with an average of seven years of experience in the pharmaceutical industry. UnitedRx is committed to performing outstanding customer service to form meaningful and long-lasting relationships to produce positive results with facilities they partner with. For more information, visit https://www.unitedrx.net.

Share article on social media or email:

[ad_2]

Zesty Paws® Enters New Product Category with All-In-One Functional Dental Bones™

[ad_1]

News Image

Our easy-to-chew and flavorful All-In-One Functional Dental Bones™ support oral health, fresh breath, and provide broader functional benefits for dogs to holistically address a pup’s gum health

Zesty Paws®, an award-winning functional pet supplement brand, is excited to announce a new product in the dental category for dogs, the All-In-One Functional Dental Bones™.

Made with wholesome ingredients like sweet potato flour, turmeric, and cinnamon, as well as EpiCor® Pets, the All-In-One Functional Dental Bones™ deliver eight key benefits to support oral health, gum health, skin and coat, joint, and gut health, as well as immune support. The treats feature ridges to fight tartar and plaque, while also supporting oral health and fresh breath, and are offered in a dog-approved flavor in small, medium, and large sizes to provide head to tail support for breeds of all sizes. In honor of this new category launch, Zesty Paws will be offering 20% off the Dental Bones collection from November 1 through November 30, using the checkout code DENTAL at zestypaws.com.

“Consumer research* validated that 91% of pet parents agree that healthy teeth and gums are essential to their dog’s overall good health and wellness, and 67% believe current dental bones in the market are good for dog’s teeth, but they wished they had other health benefits. Our easy-to-chew and flavorful All-In-One Functional Dental Bones™ support oral health, fresh breath, and provide broader functional benefits for dogs to holistically address a pup’s gum health,” said Yvethe Tyszka, Vice President of Marketing for Zesty Paws. “We’re excited to bring this outstanding solution to pet parents under their trusted brand Zesty Paws.”

Zesty Paws is also hosting a “Dig Up the Bones” sweepstakes on their website to commemorate the launch of this new product. The month-long sweepstakes will prompt participants to locate eight hidden Dental Bones images throughout the Zesty Paws website, with three winners eligible to win a full year supply of Dental Bones. For more information and to view the complete Official Rules including how to enter, eligibility and the winner selection process, visit zestypaws.com/diguptheDB.

For more information about Zesty Paws, visit http://www.zestypaws.com or follow the brand on Facebook (@ZestyPaws), Instagram (@ZestyPaws) and TikTok (@Zesty.Paws).

About Zesty Paws®

At Zesty Paws®, our passion is simple: to enable and inspire a ZEST FOR LIFE in pets and pet parents. We strive to be the most innovative and trusted brand in functional supplements to guide and empower pets on their wellness journey. Zesty Paws products have over 275,000 5-star reviews combined on Amazon, Chewy and Zestypaws.com** and have been regularly recognized as bestsellers on Amazon. Knowing that pet parents love to spoil their pets, we take pride in our commitment to striving to provide innovative and high-quality pet supplements, as well as unparalleled customer service. Zesty Paws® has been recognized by Newsweek as one of America’s Best Petcare Brands in 2022 in the Digestive Support for Dogs category. For more information visit ZestyPaws.com or follow along on social media on Instagram, Facebook, or TikTok.

*Acupoll Quantitative Research October 2021. N=506

**Ratings and reviews based on all Zesty Paws® supplements on Amazon, Chewy and ZestyPaws.com via Power Reviews as of May 31st, 2022

Share article on social media or email:



[ad_2]

RevenueWell Appoints Katherine Shuman as Chief Executive Officer

[ad_1]

Katherine Shuman

RevenueWell, the leader in patient relationship management for the dental industry, has appointed Katherine Shuman to the role of chief executive officer, the company announced today. Shuman brings decades of experience in executive leadership and a distinguished track record of leading healthcare software organizations through exceptional growth.

Shuman succeeds RevenueWell co-founder Serge Longin, who will continue to serve as a member of RevenueWell’s board of directors. Shuman is stepping into her new role after having served as RevenueWell’s chief revenue officer for the past year with responsibility for leading sales, partnerships and channels, and client services.

Prior to RevenueWell, Shuman served as chief sales officer at HealthcareSource, a leading provider of healthcare talent management solutions where she grew the business more than 40% in under five years. Prior to HealthcareSource, Shuman was chief revenue officer of Assessment Technologies Institute, a leading provider of healthcare education services, where she oversaw similar growth outcomes. She has more than two decades of experience in both software as a service and healthcare with leadership roles across multiple leading healthcare technology providers including Cerner, B.E. Smith, and LifeWatch.

“I am grateful for the opportunity to build on the tremendous momentum that Serge has created for us here at RevenueWell,” Shuman said. “Our solutions are endorsed by leading industry associations, including the American Dental Association; we have one of the largest client bases of any major dental software company; and we’ve earned top marks on software review sites for our space. We have a significant growth phase ahead, and I could not be more energized to lead the RevenueWell team forward.”

The announcement comes at a time of rapid innovation for the RevenueWell platform with recent major releases of its Insight, Phone, Forms, and Campaign solutions as well as an upcoming release of a new WinOMS integration. RevenueWell continues to drive strong quarter over quarter growth and is on track to have more than 15,000 customers by the end of 2022.

Shuman holds a Bachelor of Science degree in Business Administration and Management as well as a Master of Business Administration and Master of Healthcare Administration from Georgia State University.

About RevenueWell

RevenueWell is the only comprehensive patient relationship platform offering software and services that empower dental practices to attract the right new patients, maximize practice performance, and simplify front office operations.

RevenueWell helps solo practitioners, large DSOs, and specialists deliver better care and operate more profitability by combining ADA-endorsed, industry-leading software with award-winning support and services. RevenueWell knows dental with over 40 years of deep dental expertise serving over 14,000 thriving practices.

Share article on social media or email:

[ad_2]

Embark Behavioral Health Expands Online Services With Virtual Intensive Outpatient Program

[ad_1]

News Image

“The launch of Embark Virtual is another strategic step our team has taken toward tackling our big goal to lead the way in reversing our nation’s youth mental health crisis. Critical to achieving this big goal is creating a robust and high-quality continuum of accessible service.”

To best provide families with expert therapy that’s accessible, flexible, and convenient, Embark Behavioral Health has expanded its online mental health services with a new insurance-reimbursed virtual intensive outpatient program (IOP). The leading network of mental health treatment programs focused on adolescents, teens, and young adults launched Embark Virtual earlier this year. Embark Virtual easily connects families with industry-leading, Embark-trained therapists to find the support (counseling, coaching, and therapy) they need when they need it, from wherever they live.

“The launch of Embark Virtual is another strategic step our team has taken toward tackling our big goal to lead the way in reversing our nation’s youth mental health crisis. Critical to achieving this big goal is creating a robust and high-quality continuum of accessible service,” said Alex Stavros, CEO of Embark Behavioral Health. “Our virtual coaching, counseling, and IOP programs provide convenient ways for our clients to receive the same premium mental health care Embark is known for when attending in person is not an option or they prefer to connect with us virtually.”

Embark Virtual IOP

Embark Virtual IOP is an insurance-reimbursable program available to residents in various states across the country. Virtual IOP is ideal for adolescents, teens, and young adults as part of an after- and continuing-care plan ─ for example, when they’re stepping down from a higher level of care, such as residential treatment or wilderness therapy, or up from a lower level of care, such as weekly individual therapy.

Embark Virtual IOP offers individual, family, and group therapy as well as psychiatry and medication management services, along with delivering evidenced-based therapy via experiential activities including yoga, sculpting, music therapy, mindfulness, and painting.

Typically, adolescents, teens, and young adults in the 12-week virtual IOP program will spend three hours per day for four days per week in a variety of interactive group therapy sessions. Additionally, they’ll participate in individual sessions weekly and family therapy sessions once every other week.

“The launch of Embark Virtual IOP is a huge step toward our goal of reversing the trends of teen and young adult anxiety, depression, and suicide from all-time highs to all-time lows,” said Tiffany King, vice president of virtual at Embark Behavioral Health. “Families entering the program are supported by a multidisciplinary clinical team focused on meeting treatment objectives and outcomes. Virtual IOP is designed to be accessible, convenient, and supportive of everyday life.”

To enroll in Embark Virtual IOP, adolescents, teens, and young adults take a mental health assessment and psychiatric evaluation. A therapist will reach out to discuss goals and a treatment plan.

Embark Virtual Counseling

Embark Virtual Counseling is available across the United States. This program provides individual and family therapy as well as parent coaching. It’s ideal for:


  • Adolescents, teens, or young adults who would benefit from online therapy from the – convenience of their homes.
  • Parents who need online coaching while their child is in treatment (or anytime).
  • Families who feel they could benefit from online family therapy.

To enroll, an adolescent, teen, or young adult will first take a mental health assessment and will then be matched with a therapist. A therapist will reach out to discuss goals and a treatment plan. Parents will also be matched with a therapist based on their needs.

For more information about Embark Behavioral Health and its virtual programs, please visit http://www.embarkbh.com.

The Embark Treatment Approach

The virtual programs are guided by Embark’s unique treatment approach, which is a culmination of individual development and relationships that drive therapeutic growth. Included is Embark’s proprietary framework, CASA, which stands for commitment, acceptance, security, and attunement (also known as empathy in action) and is at the core of treatment at Embark. These universal principles of therapeutic growth are expertly delivered to clients virtually, through qualified and caring clinicians who understand how growth happens.

Embark’s virtual programs use dialectical behavior therapy (DBT), trauma-focused cognitive behavioral therapy (TF-CBT), self-management and recovery training (SMART), and experiential therapy to help with issues such as:

  • Attention-deficit/hyperactivity disorder (ADHD).
  • Anger/mood regulation.
  • Anxiety.
  • Bipolar disorder.
  • Borderline personality disorder.
  • Bullying.
  • Depression.
  • Family conflict.
  • Self-harm/cutting.
  • Social isolation.
  • Substance use/abuse.
  • Technology addiction.
  • Trauma.

ABOUT EMBARK BEHAVIORAL HEALTH

Embark Behavioral Health is a leading network of outpatient centers and residential programs offering premier mental health treatment for preteens, teens, and young adults. Dedicated to its mission of reversing the trends of teen and young adult anxiety, depression, and suicide by 2028, Embark offers a robust continuum of care with different levels of service and programming; has a deep legacy of over 25 years serving youth; works with families to adjust treatment in real time to improve results; treats the entire family using an evidence-based approach; and offers the highest levels of quality care and safety standards. For more information about Embark or its treatment programs, including virtual counseling, intensive outpatient programs (IOPs), therapeutic day treatment programs, also known as partial hospitalization programs (PHPs), short-term residential treatment, wilderness therapy, and long-term residential treatment, visit http://www.embarkbh.com.

Share article on social media or email:

[ad_2]

CommunityMed Now Offering IV Therapy for Illness and Dehydration

[ad_1]

Many people don’t realize they are dehydrated, and if it goes untreated, it can become a more serious problem. Our IV treatment option is convenient and can get people help the same day they come into the clinic.

CommunityMed Family Urgent Care, a locally owned and operated healthcare provider, has rolled out enhancements to their IV therapy to treat dehydration in patients 12 years old and older.

“Many people don’t realize they are dehydrated, and if it goes untreated, it can become a more serious problem,” said Birken Olson, CommunityMed’s CEO. “Our IV treatment option is convenient and can get people help the same day they come into the clinic.”

IV therapy is a good tool to treat dehydration from illness, too much sun or strenuous activity, and other situations.

Patients at a CommunityMed clinic are in good hands, being seen and monitored by medical professionals throughout their visit. CommunityMed has recently made updates to include a room specifically for IV therapy with comfortable chairs in each clinic. Unlike an IV bar where anyone can decide they need hydration and it’s a simple visit, patients visiting a CommunityMed clinic will be given IV therapy after an evaluation from a medical provider who has determined they would benefit from the therapy. This visit continues in a comfortable setting with licensed medical personnel. Patients would not have to go to another location to receive treatment, like they might with their primary care physician (PCP), since many PCPs do not offer this treatment in their offices.

Dehydration occurs when a person’s body loses more fluids than it takes in and can’t carry out normal functions. Symptoms include feeling thirsty, dark yellow urine, feeling tired, feeling dizzy or light-headed, confusion and less frequent urination. Dry lips, eyes and mouth can also be signs of dehydration.

Dehydration can happen more easily if a person has severe vomiting or diarrhea, been in the sun for a long period of time, consumed too much alcohol or sweated too much after exercising. People should especially be seen if they’ve had diarrhea for more than 24 hours, can’t keep fluids down or are disoriented.

CommunityMed accepts most major insurance providers, including Medicare and Tricare, as well as cash payments. Patients should always call their insurance provider to verify benefits and determine whether CommunityMed is in-network.

For more information, visit communitymedcare.com/iv-therapy/

About CommunityMed

CommunityMed Urgent Care, based in Dallas, operates walk-in medical clinics throughout North Texas in smaller towns in the North Texas region. With clinics in Arlington, Cross Roads, Haslet, Heath, Lantana, Mansfield, McKinney, Melissa, Princeton, Prosper, Southlake and Wichita Falls, CommunityMed offers first-class service, top quality care and a hometown spirit. The company has also been named to the Dallas 100 list of fastest-growing private companies by the SMU Cox Caruth Institute for Entrepreneurship for four years running. Visit the company website at CommunityMedCare.com.

Share article on social media or email:

[ad_2]

Augintel Selected for Amazon Web Services (AWS) Health Equity Initiative

[ad_1]

Augintel is a health and human services-focused software development company focused on solving longstanding problems with data — specifically, narrative unstructured data.

“We look forward to working with ACF, state child welfare organizations across the country, and AWS on our plans for using NLP and cloud technology to advance health equity nationwide,” said Marty Elisco, CEO of Augintel.

Augintel today announced that it has been selected as part of the Amazon Web Services (AWS) Health Equity Initiative, a $40 million, three-year commitment, supporting organizations that are developing solutions to advance health equity.

Through the initiative, AWS offers AWS credits and customized technical expertise to selected organizations around the world that want to use AWS services to improve health outcomes and health equity in any of the following areas:

● increasing access to health services for underserved communities

● addressing social determinants of health

● leveraging data to promote more equitable and inclusive systems of care diagnostics

● advancing equity in diagnostics and screening

The support from AWS will advance Augintel’s efforts to build a cloud-based product that helps state child welfare organizations use natural language processing (NLP) to monitor the performance of their organization. As an example, state child welfare organizations collaborate with the federal Administration for Children and Families (ACF) on Child and Family Services Reviews (CFSR), which are periodic reviews of state child welfare systems against set goals. Augintel aims to help identify critical information buried in the text of reports and assessments in order to improve the CFSR process, as well as give agencies a day-to-day, real-time view of their performance relative to the CFSR criteria.

“We are so honored to have been selected as a participant in the AWS Health Equity Initiative. We look forward to working with ACF, state child welfare organizations across the country, and AWS on our plans for using NLP and cloud technology to advance health equity nationwide,” said Marty Elisco, CEO of Augintel. “Augintel and AWS share a commitment to harnessing the power of technology to help address longstanding social and structural disparities and improve outcomes for underserved communities.”

Another intended use of Augintel’s cloud-based solution is for clinicians, who need to review an overwhelming amount of information buried within notes and health records, taking up time that could instead be spent interacting directly with those they serve. NLP can reduce this burden, saving clinicians time by automatically pulling out critical data about risk factors, strengths, and social determinants of health. This provides clinicians a more holistic view of an individual with the aim of improving the care they provide.

“AWS believes individual health outcomes should not depend on socioeconomic status, race, ethnicity, or neighborhood,” said Maggie Carter, Global Lead, Social Impact at AWS. “Cloud technology can help address the inequities in global health that have been amplified by the pandemic. Through this program, we look forward to helping Augintel use AWS to advance health equity and improve health outcomes.”

As further acknowledgement of its demonstrated experience in delivering quality solutions for government agencies, Augintel recently joined the AWS Public Sector Partner Program.

Augintel products are available for purchase in AWS Marketplace.

To learn more about the AWS Health Equity Initiative, visit https://aws.amazon.com/health/health-equity.

About Augintel

Augintel is a health and human services-focused software development company focused on solving longstanding problems with data — specifically, narrative unstructured data. We have pioneered the development of natural language processing (NLP) in our field to make narrative data accessible, searchable and actionable for staff across the organization – from front line clinicians to supervisors, quality managers and leaders. We understand that NLP products are field-specific and must be built from the ground up and tailored to specific practices in order to be successful.

Share article on social media or email:

[ad_2]

Proscia Presents Study Results On New Artificial Intelligence That Predicts Diagnostic Concordance For Melanoma

[ad_1]

Proscia’s AI relies on self-supervised learning to identify similar patterns in pathology images – much like a human sorting puzzle pieces.

“Proscia’s technology signals an exciting advancement as pathologists increasingly turn to AI to deliver on their commitment to excellent patient care,” said Dr. Kiran Motaparthi, Director of Dermatopathology and Clinical Associate Professor of Dermatology at the University of Florida.

Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance.

Conducted at the University of Florida and Thomas Jefferson University, Proscia’s retrospective study “Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression” demonstrated the AI’s performance on 1,412 whole slide images of skin biopsies. Each image was assessed by three to five dermatopathologists to establish a concordance rate. The R-squared correlation between the technology’s predictions and the dermatopathologists’ concordance rates was 0.51.[1]

In addition to this study, Proscia plans to conduct additional research illustrating the potential benefits of AI in helping pathologists to diagnose melanoma, including:


  • Lowering the misdiagnosis rate for difficult cases. Melanoma often presents like benign mimickers, causing pathologists to disagree on its diagnosis 40% of the time.[2] As cases are often evaluated by only one pathologist, AI that predicts concordance with multiple experts could help to improve diagnostic accuracy by serving as a second set of eyes.
  • Accelerating turnaround times for critical results. Over 15 million skin biopsies are taken annually in the United States[3], each of which may display one of hundreds of diagnoses. AI that predicts diagnostic agreement could flag cases that were likely to be challenging, driving efficiency gains by suggesting additional testing to provide a more complete look prior to pathologist review.
  • Reducing costs and distress for patients. Frequent over-diagnosis of melanoma not only results in additional costs for health systems but also leads patients to pay for unnecessary treatment and cope with the stress of believing they have a life-threatening disease.[4] Increased diagnostic accuracy could help to eliminate these burdens.

“Melanoma can be very challenging to diagnose,” said Dr. Kiran Motaparthi, Director of Dermatopathology and Clinical Associate Professor of Dermatology at the University of Florida. “Proscia’s technology signals an exciting advancement as pathologists increasingly turn to AI to deliver on their commitment to excellent patient care.”

Proscia’s research also indicates that the same AI could be extended to other diagnoses that demonstrate low pathologist agreement. This includes breast cancer staging[5] as well as Gleason grading of prostate cancer[6], which is used to evaluate the aggressiveness of the disease. Both often play an important role in informing treatment decisions.

“With this study, we have laid the groundwork for a new use case of AI in pathology that could have a tremendous impact on patient outcomes,” said Sean Grullon, Proscia’s Lead AI Scientist and lead author of the study. “Our technology relies on self-supervised learning to recognize incredibly subtle patterns, demonstrating the power of one of the most advanced approaches in AI.”

About Proscia

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.

[1] Grullon, S. Spurrier, V., Zhao, J. , Chivers, C., Jiang, Y. Motaparthi, K. Lee, J., Bonham, M. and Ianni, J. Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression. Accepted to the European Conference of Computer Vision (ECCV) 2022 AI in Medical Imaging Workshop. arXiv:2210.04803

[2] Elmore, J.G., Barnhill, R.L., Elder, D.E., Longton, G.M., Pepe, M.S., Reisch, L.M., Carney, P.A., Titus, L.J., Nelson, H.D., Onega, T., et al.: Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 357 (2017)

[3] Klipp, J. (2019). The U.S. Anatomic Pathology Market: Forecast & Trends 2019-2021. Laboratory Economics. Poughkeepsie, NY.

[4] Welch, H.G., Mazer, B.L., Adamson, A.S.: The rapid rise in cutaneous melanoma diagnoses. The New England journal of medicine 384(1), 72–79 (2021)

[5] Plichta, J.K., Thomas, S.M., Sergesketter, A.R., Greenup, R.A., Fayanju, O.M., Rosenberger, L.H., Tamirisa, N., Hyslop, T., Hwang, E.S.: Clinical and pathological stage discordance among 433,514 breast cancer patients. Am J Surg 218(4), 669– 676 (10 2019)

[6] Coard, K.C., Freeman, V.L.: Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. Am J Clin Pathol 122(3), 373–376 (Sep 2004)

Share article on social media or email:

[ad_2]

Press Release News Wire Service